Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NBIX
Recent news which mentions NBIX
< Previous
1
2
3
4
5
Next >
Analyst Ratings For Neurocrine Biosciences
January 07, 2022
Tickers
NBIX
Tags
BZI/AAR
Analyst Ratings
NBIX
From
Benzinga
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
January 07, 2022
Tickers
AMLX
CINC
FDMT
GKOS
Tags
VIGL
Market News
Guidance
From
Benzinga
Expert Ratings For Neurocrine Biosciences
December 08, 2021
Tickers
NBIX
Tags
Market News
Benzinga
NBIX
From
Benzinga
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
Tickers
ACET
AMAM
AMRX
BIIB
Tags
NBIX
General
EYPT
From
Benzinga
Neurocrine's Ingrezza Meets Primary Goal In Phase 3 Study In Patients With Involuntary Muscle Movement
December 08, 2021
Tickers
NBIX
Tags
Briefs
Phase 3 Trial
Benzinga
From
Benzinga
Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets
November 22, 2021
Tickers
NBIX
Tags
Briefs
Schizophrenia
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
Tickers
ABCL
ACGL
AIG
AJG
Tags
HIG
PGR
HAL
From
Benzinga
Mobile Mental Health: Coming to a Home Near You?
November 18, 2021
Tickers
KTTA
LLY
NBIX
Tags
Health Care
LLY
Benzinga
From
Benzinga
Analyst Ratings For Neurocrine Biosciences
November 17, 2021
Tickers
NBIX
Tags
NBIX
Analyst Ratings
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021
November 17, 2021
Tickers
AA
ADMS
AMWD
APA
Tags
CLF
Upgrades
STRO
From
Benzinga
71 Biggest Movers From Yesterday
November 03, 2021
Tickers
ABVC
ADCT
ANET
AUTO
Tags
Financials
Movers From Yesterday
OLB
From
Benzinga
Why Neurocrine Biosciences Shares Fell Nearly 10% Today
November 02, 2021
Tickers
NBIX
Tags
Market News
NBIX
From
Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 02, 2021
Tickers
ALDX
BFRI
BNGO
CALT
Tags
KNSA
BFRI
ALDX
From
Benzinga
What 5 Analyst Ratings Have To Say About Neurocrine Biosciences
November 02, 2021
Tickers
NBIX
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Tickers
AADI
AMGN
AVNS
CNTX
Tags
IART
Small Cap
General
From
Benzinga
Neurocrine Biosciences, Inc (NBIX) Q3 2021 Earnings Call Transcript
November 01, 2021
Tickers
NBIX
Tags
NBIX
Market News
From
Motley Fool
12 Health Care Stocks Moving In Monday's After-Market Session
November 01, 2021
Tickers
BCEL
BPTS
ETON
GERN
Tags
BPTS
Market News
MDGS
From
Benzinga
Neurocrine Biosciences: Q3 Earnings Insights
November 01, 2021
Tickers
NBIX
Tags
BZI/Recaps
NBIX
Benzinga
From
Benzinga
Neurocrine Biosciences's Return On Capital Employed Overview
November 01, 2021
Tickers
NBIX
Tags
BZI/ROCE
NBIX
Benzinga
From
Benzinga
Earnings Scheduled For November 1, 2021
November 01, 2021
Tickers
ADC
ADTN
ADUS
AKTS
Tags
CURO
WTRG
RRX
From
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers
ADPT
AERI
AGIO
ALGS
Tags
EQ
AERI
SYNH
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
October 14, 2021
Tickers
ABT
ACAD
AIRG
AIZ
Tags
PLOW
ABT
Intraday Update
From
Benzinga
3 Biotech Stocks With Huge Catalysts This Fall
September 29, 2021
Tickers
BIIB
CMPS
IONS
NBIX
Tags
IONS
CMPS
BIIB
From
Motley Fool
Looking into Neurocrine Biosciences's Return on Capital Employed
August 20, 2021
Tickers
NBIX
Tags
Market News
Benzinga
Earnings
From
Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
Tickers
ABVC
ACAD
ACHL
ADGI
Tags
ZIVO
RMTI
GRFS
From
Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Tickers
ABCL
ACET
ACHV
ADGI
Tags
General
ADGI
TCON
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 11, 2021
Tickers
ICLK
INNV
KMDA
KNSA
Tags
ZGNX
OTIC
NAUT
From
Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Tickers
ACAD
ACHV
ADMA
AKRO
Tags
KPTI
TFFP
STOK
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 6, 2021
August 06, 2021
Tickers
ADTN
AES
ATUS
BCE
Tags
ITRI
Upgrades
TGI
From
Benzinga
Neurocrine Biosciences, inc (NBIX) Q2 2021 Earnings Call Transcript
August 03, 2021
Tickers
NBIX
Tags
NBIX
Market News
From
Motley Fool
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.